The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Chipotle Mexican Grill, IBM, Level 3 Communications, Netflix, PayPal and Salesforce.com.
Now is the time to look for good growth stocks as the second half of the year could have solid upside after a flat first half.
In a recent research report, Jefferies is out with its top growth stock calls to kick off June, and we found three that look very attractive now and that also seem to…
Here are seven speculative biotech and biohealth players in which analyst calls during the week ending May 27 have given major upside projections.
These four solid growth companies are trading well below recent highs and the Jefferies price targets. With very solid upside potential, they look extremely good now.
The top analyst upgrades, downgrades and initiations seen on Monday morning include Alcoa, Boston Scientific, Schlumberger, Sony and Staples.
New research from Jefferies highlights this week's top growth stock picks, and there is a clear bias for some top biotech and pharmaceutical stocks — and with good reason. They are cheap…
Lee Jackson This week's top U.S. growth calls from the analysts at Jefferies focus on companies that have some outstanding upside potential, including the following three leading biotech stocks.
Lee Jackson Like others on Wall Street, the analysts at the specialty biotech and health care boutique firm Leerink see 2016 as a year with some uncertainty.
Lee Jackson Neurocrine Biosciences made waves in the market on Thursday morning after it announced positive results in a Phase 3 trial.
Chris Lange In a new report from Jefferies, three top growth stocks hit their screens and they all have substantial upside potential for aggressive growth investors.
Cowen sees the potential for super-mergers in biotech, as well as a large group of smaller targets that may be in the sights of bigger companies now.
Lee Jackson Thursday's top analyst upgrades and downgrades include Chesapeake Energy, eBay, Enterprise Products Partners, Gilead Sciences, Newmont Mining and Wynn Resorts.
Wednesday's top analyst upgrades, downgrades and initiations includes Alcoa, Apache, Bob Evans, F5, Hain and McDonald's.
Neurocrine Biosciences has announced that it will have another public offering of its common stock to raise roughly $225 million.
